Medical Device Eventos em Netherlands

Por setor
Tópico relacionado
Data

World EPA Congress

Março 03, 2026 - Março 04, 2026

World EPA Congress sets the global agenda for healthcare evidence, pricing and access

The World EPA Congress is recognized as a world-leading platform dedicated to healthcare evidence, pricing, and access. At a time when healthcare systems are under growing pressure from rising costs, demographic change, and rapid innovation, the congress brings clarity to some of the most complex questions facing the industry today. It serves as a meeting point for decision-makers who shape how medicines and therapies reach patients across global markets.

Focused on evidence-driven decision-making, the World EPA Congress connects science, policy, and strategy. It addresses the full spectrum of challenges surrounding market access and reimbursement, while keeping patient outcomes at the center of discussion. By combining strategic insight with practical expertise, the congress helps organizations navigate an increasingly demanding healthcare environment.

More than a conference, the World EPA Congress functions as a working forum for alignment between stakeholders who influence healthcare value.

A comprehensive focus on market access, pricing and reimbursement

One of the defining strengths of the World EPA Congress is its holistic approach. The event covers the full lifecycle of healthcare evidence and access, reflecting how interconnected these topics have become. Discussions move beyond theory and focus on how pricing and reimbursement decisions are made in real-world settings.

Core areas of focus include:

Market access strategy across global and regional markets

Pricing models and value-based approaches

Reimbursement pathways and payer expectations

Health technology assessments and decision frameworks

These themes are explored through practical case studies, expert panels, and strategic sessions. Participants gain insight into how evidence is evaluated, how value is demonstrated, and how access strategies can be adapted to diverse healthcare systems.

By addressing both mature and emerging markets, the congress offers a truly global perspective.

Advancing healthcare through evidence and outcomes research

Evidence lies at the heart of sustainable healthcare decisions, and the World EPA Congress places strong emphasis on its generation and application. Health economics and outcomes research play a critical role in demonstrating value, informing policy, and supporting patient-centered care.

Key topics explored include:

Real-world evidence and its role in decision-making

Health economics models supporting value demonstration

Outcomes research aligned with payer and patient needs

These discussions highlight how robust data can bridge the gap between innovation and access. By aligning clinical, economic, and real-world perspectives, stakeholders can better support informed, transparent decisions that benefit healthcare systems and patients alike.

Addressing rare diseases and specialized healthcare challenges

Rare diseases represent one of the most complex areas of modern healthcare, and the World EPA Congress dedicates focused attention to this field. The challenges of limited patient populations, high development costs, and evolving regulatory expectations require tailored approaches to pricing and access.

The congress provides a platform for dialogue on:

Innovative access models for rare and orphan diseases

Evidence generation in small populations

Collaboration between manufacturers, payers, and patient groups

These conversations recognize that traditional frameworks often fall short when applied to rare diseases. By sharing experience and best practices, participants contribute to more flexible, patient-focused solutions.

Connecting solution providers with healthcare decision-makers

With more than 120 leading solution providers participating, the World EPA Congress offers direct access to expertise across the healthcare value chain. These organizations support operational excellence in areas such as evidence generation, market access execution, pricing strategy, and data analytics.

Participants benefit from engaging with providers specializing in:

Evidence and data solutions

Market access consulting and implementation

Pricing and reimbursement analytics

Rare disease strategy and support

This ecosystem allows attendees to identify partners who can help translate strategy into execution. The emphasis is not only on ideas, but on actionable solutions that deliver measurable impact.

A global forum shaping the future of healthcare access

The World EPA Congress stands out for its ability to bring together diverse perspectives in a structured and collaborative environment. Industry leaders, policymakers, payers, researchers, and solution providers engage in open dialogue aimed at improving healthcare access while ensuring system sustainability.

By combining thought leadership with practical expertise, the congress helps shape future standards in evidence, pricing, and access. It reinforces the importance of collaboration in a landscape where no single stakeholder can address challenges alone.

For professionals seeking to stay ahead of evolving healthcare expectations, the World EPA Congress remains an essential event a place where evidence meets strategy, access meets innovation, and the future of global healthcare takes form.

CDMO Live

maio 27, 2026 - maio 28, 2026

A Central Platform for the CDMO and Biopharma Community

The concept behind CDMO Live is rooted in collaboration and technological progress. In an era where outsourcing plays an increasingly critical role in pharmaceutical production, this event provides a targeted, high-value platform for knowledge exchange, deal-making, and strategic alignment between developers, manufacturers, and service providers.

The annual gathering in Rotterdam provides an exceptional opportunity for participants to learn about emerging technologies, regulatory developments, and market dynamics in contract manufacturing. Whether it’s biologics, small molecules, or advanced therapies, the conference offers insights into every stage of the drug development and production lifecycle.

Key Objectives of CDMO Live

Facilitating Collaboration – connecting biopharma companies with trusted outsourcing partners.

Showcasing Innovation – presenting cutting-edge technologies and manufacturing solutions.

Sharing Expertise – offering a forum for thought leaders to discuss trends, challenges, and opportunities.

Driving Efficiency – helping organizations streamline development and production workflows.

Through this strategic focus, CDMO Live enables participants to navigate the rapidly evolving biopharmaceutical outsourcing landscape with clarity and confidence.

Rotterdam: A Strategic Hub for Biopharma Collaboration

The choice of Rotterdam as the host city reflects the event’s global and forward-looking perspective. As one of Europe’s most important logistical and industrial centers, Rotterdam provides a vibrant environment for international collaboration in science, trade, and technology.

The city’s modern infrastructure, excellent transport connections, and proximity to leading European biotech hubs make it an ideal venue for global professionals seeking to expand their networks. The event’s venue equipped with state-of-the-art conference and exhibition spaces—fosters meaningful discussions and high-level business interactions in a professional yet inspiring setting.

Why Rotterdam Is the Perfect Host City

Strategic European location with easy access to major biopharma clusters.

Strong life sciences ecosystem, home to research institutes and innovative companies.

World-class conference facilities supporting global events and exhibitions.

Commitment to sustainability and innovation, aligning with the future of pharma.

Rotterdam’s atmosphere of progress and connectivity perfectly complements CDMO Live’s mission to unite the global CDMO community under one roof.

A Specialized Forum for the Future of Biopharmaceutical Manufacturing

At the heart of CDMO Live lies a sharp focus on advancements in small molecules, biologics, and cell & gene therapy three pillars of modern biopharmaceutical innovation. The conference and exhibition highlight technologies and outsourcing strategies that help companies adapt to increasing regulatory complexity, rising production costs, and accelerating product timelines.

The event goes beyond conventional trade fairs by offering in-depth discussions, technical presentations, and strategic networking opportunities. This approach ensures that attendees gain actionable insights and build partnerships that extend far beyond the duration of the event.

Core Themes and Discussion Topics

Innovations in Biologics and Biosimilars – advancing production and quality assurance.

Cell and Gene Therapy Manufacturing – overcoming technical and scalability challenges.

Process Optimization and Digitalization – integrating AI, automation, and data analytics.

Regulatory Compliance and Global Supply Chains – addressing market access and safety.

Outsourcing Strategy and Risk Management – balancing flexibility with long-term partnerships.

By focusing on these themes, CDMO Live encourages participants to embrace innovation, mitigate challenges, and redefine efficiency in pharmaceutical manufacturing.

PharmaSource and Life Science Networks: The Visionaries Behind the Event

The driving force behind CDMO Live is the partnership between PharmaSource and Life Science Networks, two organizations committed to supporting growth and excellence within the life sciences industry.

PharmaSource is a well-established platform providing professionals with market insights, industry news, podcasts, and training programs focused on procurement and outsourcing. It acts as a resource hub for understanding best practices and staying up to date with global market movements.

Behind PharmaSource stands Life Science Networks, a leading organizer of specialized events and industry collaborations. Together, they have shaped CDMO Live into a trusted meeting ground where knowledge, innovation, and opportunity intersect.

Their Shared Mission

Empowering professionals through access to relevant and timely information.

Building networks that connect companies across the value chain.

Driving innovation by organizing events that inspire collaboration.

Enhancing industry standards through education and communication.

This partnership ensures that CDMO Live is not just another event it is a strategic experience designed to strengthen the global CDMO community.

PartnerMatch: Facilitating One-on-One Business Connections

A highlight of CDMO Live is the PartnerMatch 1-on-1 meeting program, which provides an efficient and personalized way for companies to identify and connect with potential partners. This initiative allows participants to schedule face-to-face business meetings, maximizing their time and creating tangible collaboration opportunities.

Alongside PartnerMatch, the event hosts roundtable discussions, market analyses, and panel sessions that explore real-world challenges and success stories. These sessions foster open dialogue between executives, scientists, and consultants ensuring a 360-degree view of the industry’s most pressing topics.

Networking and Engagement Opportunities

PartnerMatch 1-on-1 Meetings – targeted networking for partnership development.

Roundtable Discussions – in-depth exploration of industry trends.

Workshops and Case Studies – sharing practical approaches to outsourcing challenges.

Market Insight Panels – featuring leaders from top CDMO and biotech organizations.

This interactive environment turns CDMO Live into a collaborative knowledge hub, where strategy meets innovation and business development takes on new dimensions.

Where the Future of Outsourcing Takes Shape

The CDMO Live conference and exhibition has rapidly positioned itself as a must-attend event for professionals in the pharmaceutical and biotechnology sectors. By bringing together thought leaders, manufacturers, and service providers, it has become a cornerstone of the global outsourcing and manufacturing landscape.

Hosted annually in Rotterdam and organized by PharmaSource and Life Science Networks, CDMO Live provides not just a showcase of innovation but also a forum for action where ideas turn into partnerships and strategies evolve into tangible results.

For organizations aiming to stay at the forefront of biopharmaceutical manufacturing, CDMO Live is more than an event it’s a strategic opportunity to explore the latest trends, build lasting collaborations, and prepare for the next chapter of the life sciences industry.